Patrick James Orme

Array ( [id] => 7361843 [patent_doc_number] => 20040014700 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents' [patent_app_type] => new [patent_app_number] => 10/203398 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9886 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20040014700.pdf [firstpage_image] =>[orig_patent_app_number] => 10203398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1050234 [patent_doc_number] => 06861513 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-03-01 [patent_title] => 'Everninomicin biosynthetic genes' [patent_app_type] => utility [patent_app_number] => 09/758759 [patent_app_country] => US [patent_app_date] => 2001-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 128 [patent_figures_cnt] => 55 [patent_no_of_words] => 19112 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/861/06861513.pdf [firstpage_image] =>[orig_patent_app_number] => 09758759 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 536668 [patent_doc_number] => 07173122 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-02-06 [patent_title] => 'Antisense oligonucleotides to type I procollagen' [patent_app_type] => utility [patent_app_number] => 10/149352 [patent_app_country] => US [patent_app_date] => 2000-12-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1993 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/173/07173122.pdf [firstpage_image] =>[orig_patent_app_number] => 10149352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 768718 [patent_doc_number] => 07005258 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-02-28 [patent_title] => 'Cdc25 genes, encoded products and uses thereof' [patent_app_type] => utility [patent_app_number] => 09/699580 [patent_app_country] => US [patent_app_date] => 2000-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 21147 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/005/07005258.pdf [firstpage_image] =>[orig_patent_app_number] => 09699580 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1594101 [patent_doc_number] => 06383808 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-07 [patent_title] => 'Antisense inhibition of clusterin expression' [patent_app_type] => B1 [patent_app_number] => 09/659791 [patent_app_country] => US [patent_app_date] => 2000-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23634 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/383/06383808.pdf [firstpage_image] =>[orig_patent_app_number] => 09659791 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 860687 [patent_doc_number] => 07371833 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-05-13 [patent_title] => 'Nucleic acid molecules with specific recognition of native PrPSc, production and use' [patent_app_type] => utility [patent_app_number] => 09/744934 [patent_app_country] => US [patent_app_date] => 2000-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 7518 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/371/07371833.pdf [firstpage_image] =>[orig_patent_app_number] => 09744934 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 341642 [patent_doc_number] => 07501400 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-03-10 [patent_title] => 'Inhibition of gastric acid production and/or secretion' [patent_app_type] => utility [patent_app_number] => 09/979666 [patent_app_country] => US [patent_app_date] => 2000-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 39231 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501400.pdf [firstpage_image] =>[orig_patent_app_number] => 09979666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7612629 [patent_doc_number] => 06903206 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-07 [patent_title] => 'Kits for amplifying target nucleic acid sequences using modified oligonucleotides' [patent_app_type] => utility [patent_app_number] => 09/523237 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 21250 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/903/06903206.pdf [firstpage_image] =>[orig_patent_app_number] => 09523237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6683900 [patent_doc_number] => 20030119764 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'Induction of viral mutation by incorporation of miscoding ribonucleoside analogs into viral RNA' [patent_app_type] => new [patent_app_number] => 09/522373 [patent_app_country] => US [patent_app_date] => 2000-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 13435 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0119/20030119764.pdf [firstpage_image] =>[orig_patent_app_number] => 09522373 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 303635 [patent_doc_number] => 07534773 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2009-05-19 [patent_title] => 'TRPM-2 antisense therapy' [patent_app_type] => utility [patent_app_number] => 09/913325 [patent_app_country] => US [patent_app_date] => 2000-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 16 [patent_no_of_words] => 4851 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/534/07534773.pdf [firstpage_image] =>[orig_patent_app_number] => 09913325 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 520341 [patent_doc_number] => 07189832 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-03-13 [patent_title] => 'Gamma subunit of cytokine responsive IκB-alpha kinase complex and methods of using same' [patent_app_type] => utility [patent_app_number] => 09/377795 [patent_app_country] => US [patent_app_date] => 1999-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 15986 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/189/07189832.pdf [firstpage_image] =>[orig_patent_app_number] => 09377795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 750823 [patent_doc_number] => 07022831 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-04-04 [patent_title] => 'Regulation of BCL-2 gene expression' [patent_app_type] => utility [patent_app_number] => 09/375514 [patent_app_country] => US [patent_app_date] => 1999-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 32 [patent_no_of_words] => 15020 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/022/07022831.pdf [firstpage_image] =>[orig_patent_app_number] => 09375514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6882964 [patent_doc_number] => 20010049436 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'MIXED-BACKBONE OLIGONUCLEOTIDES CONTAINING POPS BLOCKS TO OBTAIN REDUCED PHOSPHOROTHIOATE CONTENT' [patent_app_type] => new [patent_app_number] => 09/283431 [patent_app_country] => US [patent_app_date] => 1999-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 4691 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20010049436.pdf [firstpage_image] =>[orig_patent_app_number] => 09283431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 675929 [patent_doc_number] => 07087581 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-08-08 [patent_title] => 'Method for the treatment of diseases or disorders of the inner ear' [patent_app_type] => utility [patent_app_number] => 09/622719 [patent_app_country] => US [patent_app_date] => 1999-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4048 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/087/07087581.pdf [firstpage_image] =>[orig_patent_app_number] => 09622719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 620248 [patent_doc_number] => 07141665 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-11-28 [patent_title] => 'Enzymatic DNA molecules' [patent_app_type] => utility [patent_app_number] => 09/423035 [patent_app_country] => US [patent_app_date] => 1998-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 27401 [patent_no_of_claims] => 58 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/141/07141665.pdf [firstpage_image] =>[orig_patent_app_number] => 09423035 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 479254 [patent_doc_number] => 07223849 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-05-29 [patent_title] => 'Oligonucleotides from the untranslated regions of housekeeping genes and methods of using same to modulate cell growth' [patent_app_type] => utility [patent_app_number] => 09/214386 [patent_app_country] => US [patent_app_date] => 1997-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16548 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/223/07223849.pdf [firstpage_image] =>[orig_patent_app_number] => 09214386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4038316 [patent_doc_number] => 05856455 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-05 [patent_title] => 'Gapped 2\'-modified oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/861306 [patent_app_country] => US [patent_app_date] => 1997-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14114 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/856/05856455.pdf [firstpage_image] =>[orig_patent_app_number] => 861306 [rel_patent_id] =>[rel_patent_doc_number] =>)